IP Library › Granted Patent US 12,745,901
Granted Patent B2
US 12,745,901 · App. 18/784,291 · Granted Sep 29, 2026

Systems and methods for detecting failure in plasma treatment

Inventors: Adam Sagiv (Moshav Bnei Atarot, IL); Amnon Lam (Kibutz Givat Oz, IL)
Assignee: PLASMATICA LTD.
A61B1/127A61B90/70H05H1/2406A61B2090/701
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,745,901
App. No.
18/784,291
Granted
Sep 29, 2026
Kind
B2
Abstract

Systems, devices, methods, and computer readable media for generating plasma for treating objects may be provided. Embodiments include a housing; a plasma-generation zone within the housing configured to enable accommodation of an object; circuitry for supplying energy to carry out a plasma treatment for increasing hydrophilicity of the object to a desired level; at least one sensor configured to measure at least one plasma-activation parameter during the plasma treatment; and at least one processor configured to: determine, based on the at least one plasma-activation parameter, that the plasma treatment is below a threshold for increasing the hydrophilicity of the object to the desired level; and output a notification indicating plasma treatment failure.

Claims (37)

1 . A plasma generation device for treating objects, the device comprising:

a housing;

a plasma-generation zone within the housing configured to enable accommodation of an object;

circuitry for supplying energy to carry out a plasma treatment for increasing hydrophilicity of the object to a desired level;

at least one sensor configured to measure at least one plasma-activation parameter during the plasma treatment; and

at least one processor configured to:

determine, based on the at least one plasma-activation parameter, that the plasma treatment is below a threshold for increasing the hydrophilicity of the object to the desired level; and

output a notification indicating plasma treatment failure.

2 . The plasma generation device of claim 1 , wherein the at least one sensor is configured to measure the at least one plasma-activation parameter by detecting a pressure in the plasma-generating zone during the plasma treatment, and wherein the at least one processor is further configured to determine that the plasma treatment fails to meet the threshold when the pressure is outside a pressure range.

3 . The plasma generation device of claim 1 , wherein the at least one sensor is configured to measure the at least one plasma-activation parameter by detecting a voltage at an electrode generating the plasma during the plasma treatment, and wherein the at least one processor is further configured to determine that the plasma treatment fails to meet the threshold when the detected voltage is outside a voltage range.

4 . The plasma generation device of claim 1 , wherein the at least one sensor is configured to measure the at least one plasma-activation parameter by detecting a plasma frequency during the plasma treatment, and wherein the at least one processor is configured to determine that the plasma treatment fails to meet the threshold when the detected plasma frequency is outside a plasma frequency range.

5 . The plasma generation device of claim 1 , further comprising a gas reservoir configured to stream a gas into the plasma-generation zone for carrying out the plasma treatment, wherein the at least one processor is further configured to determine that the plasma treatment fails to meet the threshold based on a characteristic of the gas.

6 . The plasma generation device of claim 1 , wherein the at least one sensor includes at least one of a pressure sensor, a voltage sensor, or a plasma frequency sensor.

7 . The plasma generation device of claim 1 , wherein the object includes an optical element.

8 . The plasma generation device of claim 1 , wherein the object is an endoscope, wherein the plasma generation device further comprises a detachable sheath dimensioned to receive a distal end of the endoscope, and wherein the plasma-generation zone is configured to apply the plasma treatment to the distal end of the endoscope within the sheath.

9 . The plasma generation device of claim 1 , wherein the object is at least a portion of a medical instrument and wherein the at least one processor is further configured to output the notification indicating plasma treatment failure prior to using the medical instrument in a medical procedure.

10 . The plasma generation device of claim 1 , wherein the at least one processor is further configured to maintain the plasma treatment for a predefined time duration.

11 . The plasma generation device of claim 10 , wherein the predefined time duration is based on a characteristic of plasma generated for the plasma treatment.

12 . The plasma generation device of claim 10 , wherein the predefined time duration is based on a physical characteristic of the object.

13 . The plasma generation device of claim 10 , wherein the predefined time duration is based on the desired level of hydrophilicity of the object.

14 . The plasma generation device of claim 10 , wherein the at least one processor is further configured to increase a time duration for a subsequent plasma treatment in response to determining that that the plasma treatment is below the threshold.

15 . The plasma generation device of claim 1 , wherein the plasma-generation zone is associated with a cavity configured to retain the object in a manner exposing at least a portion of the object to the plasma-generation zone.

16 . The plasma generation device of claim 1 , wherein the plasma-generation zone is configured to contain a plasma cloud on a first side of a dielectric barrier while the object is located on a second side of the dielectric barrier.

17 . The plasma generation device of claim 1 , further comprising a plasma generator configured to be activated to cause formation of a plasma cloud in the plasma-generation zone, and wherein the at least one processor is further configured to activate the plasma generator for a time period sufficient to increase the hydrophilicity of the object to the desired level.

18 . The plasma generation device of claim 1 , wherein the desired level of hydrophilicity of the object is such that at least one hour after the plasma treatment, droplets hitting a surface of the object have contact angles of less than 10 degrees.

19 . A method for generating plasma to treat an object, the method comprising:

identifying entry of an object into a plasma-generation zone;

activating circuitry for supplying energy to generate plasma in the plasma-generation zone to carry out a plasma treatment for increasing hydrophilicity of the object to a desired level;

measuring at least one plasma-activation parameter during the plasma treatment;

determining, based on the at least one plasma-activation parameter, that the plasma treatment is below a threshold for increasing the hydrophilicity of the object to the desired level; and

outputting a notification indicating plasma treatment failure.

20 . A non-transitory computer readable medium containing instructions that when executed by at least one processor cause the at least one processor to perform operations for generating plasma to treat an object, the operations comprising:

identifying entry of an object into a plasma-generation zone;

activating circuitry for supplying energy to generate plasma in the plasma-generation zone to carry out a plasma treatment for increasing hydrophilicity of the object to a desired level;

measuring at least one plasma-activation parameter during the plasma treatment;

determining, based on the at least one plasma-activation parameter, that the plasma treatment is below a threshold for increasing the hydrophilicity of the object to the desired level; and

outputting a notification indicating plasma treatment failure.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2024
From: SAGIV, ADAM; LAM, AMNON
To: PLASMATICA LTD.
Reel/Frame 068085/0362 →
Priority Claims (1)
IL 288770 · Dec 7, 2021 · national
Continuity (4)
Continuation 18491630 · Oct 20, 2023
Continuation PCTIB2022000240 · Apr 22, 2022
Provisional Application 63178024 · Apr 22, 2021
Related Publication 20240374127A1 · Nov 14, 2024
References Cited (135)
US 3925178A · Gesser et al. · 1975 [cited by applicant]
US 4055378A · Feneberg et al. · 1977 [cited by applicant]
US 4122942A · Wolfson · 1978 [cited by applicant]
US 4143949A · Chen · 1979 [cited by applicant]
US 4214014A · Höfer et al. · 1980 [cited by applicant]
US 4312575A · Peyman et al. · 1982 [cited by applicant]
US 4632844A · Yanagihara et al. · 1986 [cited by applicant]
US 4643876A · Jacobs et al. · 1987 [cited by applicant]
US 4827870A · Lee · 1989 [cited by examiner]
US 5009920A · Lee · 1991 [cited by examiner]
US 6855329B1 · Shakesheff et al. · 2005 [cited by applicant]
US 7078074B2 · Matsuzawa · 2006 [cited by examiner]
US 7931584B2 · Akagi et al. · 2011 [cited by applicant]
US 7985188B2 · Felts · 2011 [cited by examiner]
US 8047215B1 · Sasaki · 2011 [cited by applicant]
US 8168130B2 · Sato et al. · 2012 [cited by applicant]
US 8328982B1 · Babayan · 2012 [cited by examiner]
US 8349125B2 · Vane et al. · 2013 [cited by applicant]
US 8409077B2 · Orihara et al. · 2013 [cited by applicant]
US 8475451B2 · Cho · 2013 [cited by applicant]
US 8501106B2 · Sato et al. · 2013 [cited by applicant]
US 8618435B2 · Bohori · 2013 [cited by examiner]
US 8663625B2 · Stroock et al. · 2014 [cited by applicant]
US 8696983B2 · Hayashi et al. · 2014 [cited by applicant]
US 9072443B2 · Hashido et al. · 2015 [cited by applicant]
US 9248207B1 · Heyoung · 2016 [cited by applicant]
US 10413168B2 · Sagiv · 2019 [cited by examiner]
US 10596287B2 · Dang et al. · 2020 [cited by applicant]
US 10755901B2 · Chambers · 2020 [cited by examiner]
US 10820402B2 · Lam · 2020 [cited by examiner]
US 10827601B1 · Williams · 2020 [cited by examiner]
US 10857372B2 · Zuidervaart · 2020 [cited by examiner]
US 10923331B1 · Williams · 2021 [cited by examiner]
US 11243393B2 · Lam · 2022 [cited by examiner]
US 11246480B2 · Sagiv · 2022 [cited by examiner]
US 11533801B2 · Boughton · 2022 [cited by examiner]
US 11715321B2 · Hiemstra · 2023 [cited by examiner]
US 11896203B2 · Sagiv · 2024 [cited by examiner]
US 11896204B2 · Sagiv · 2024 [cited by examiner]
US 11974728B2 · Sagiv et al. · 2024 [cited by applicant]
US 12070193B2 · Sagiv · 2024 [cited by examiner]
US 12262877B2 · Sagiv · 2025 [cited by examiner]
US 20020053353A1 · Kawata et al. · 2002 [cited by applicant]
US 20040037736A1 · Perruchot et al. · 2004 [cited by applicant]
US 20040084146A1 · Sekiya · 2004 [cited by applicant]
US 20050045589A1 · Rastogi et al. · 2005 [cited by applicant]
US 20060252986A1 · Akagi et al. · 2006 [cited by applicant]
US 20070078245A1 · Hoffman · 2007 [cited by examiner]
US 20080002146A1 · Stachowski et al. · 2008 [cited by applicant]
US 20080243032A1 · Hindelang et al. · 2008 [cited by applicant]
US 20100094090A1 · Mejia · 2010 [cited by examiner]
US 20100249503A1 · Yazawa · 2010 [cited by examiner]
US 20100286479A1 · Ashida · 2010 [cited by examiner]
US 20100292537A1 · Ashida · 2010 [cited by examiner]
US 20110283477A1 · Ashpis · 2011 [cited by examiner]
US 20110301412A1 · Cho · 2011 [cited by applicant]
US 20130137928A1 · Karasawa et al. · 2013 [cited by applicant]
US 20140290700A1 · Langford · 2014 [cited by applicant]
US 20140371528A1 · Yen et al. · 2014 [cited by applicant]
US 20150005582A1 · Poll et al. · 2015 [cited by applicant]
US 20150035918A1 · Matsumoto et al. · 2015 [cited by applicant]
US 20150209461A1 · Itarashiki et al. · 2015 [cited by applicant]
US 20150380681A1 · Furukawa · 2015 [cited by examiner]
US 20160068960A1 · Jung et al. · 2016 [cited by applicant]
US 20160331437A1 · Holbeche et al. · 2016 [cited by applicant]
US 20180138022A1 · Lam et al. · 2018 [cited by applicant]
US 20180221610A1 · Larson · 2018 [cited by examiner]
US 20180305019A1 · Hubschwerlen · 2018 [cited by examiner]
US 20190021584A1 · Sagiv · 2019 [cited by examiner]
US 20190365215A1 · Sagiv · 2019 [cited by examiner]
US 20200023997A1 · Lowe · 2020 [cited by examiner]
US 20200077505A1 · Lam · 2020 [cited by examiner]
US 20200118674A1 · Le · 2020 [cited by examiner]
US 20200196912A1 · Ariyama · 2020 [cited by examiner]
US 20210023250A1 · Golkowski et al. · 2021 [cited by applicant]
US 20210041690A1 · Lam · 2021 [cited by examiner]
US 20220125291A1 · Sagiv · 2022 [cited by examiner]
US 20220203014A1 · Shuler · 2022 [cited by examiner]
US 20220240770A1 · Sagiv · 2022 [cited by examiner]
US 20220257105A1 · Sagiv · 2022 [cited by examiner]
US 20220366719A1 · Hiemstra · 2022 [cited by examiner]
US 20230351797A1 · Hiemstra · 2023 [cited by examiner]
US 20240049958A1 · Sagiv · 2024 [cited by examiner]
US 20240138664A1 · Sagiv · 2024 [cited by examiner]
US 20240374127A1 · Sagiv · 2024 [cited by examiner]
CA 3035491A1 · 2017 [cited by applicant]
CA 3216142A1 · 2022 [cited by examiner]
CN 102006831A · 2011 [cited by applicant]
CN 102512702A · 2012 [cited by applicant]
CN 103585650A · 2014 [cited by applicant]
CN 104661422A · 2015 [cited by applicant]
CN 204618406U · 2015 [cited by applicant]
CN 108135463B · 2020 [cited by applicant]
CN 111789568A · 2020 [cited by applicant]
EP 0302419A2 · 1989 [cited by applicant]
EP 1110557A2 · 2001 [cited by applicant]
EP 1867683A1 · 2007 [cited by applicant]
EP 1889562A1 · 2008 [cited by applicant]
EP 2115499A0 · 2009 [cited by applicant]
EP 3346901B1 · 2020 [cited by applicant]
EP 3813495A1 · 2021 [cited by applicant]
GB 2286200A · 1995 [cited by applicant]
IL 279819B · 2021 [cited by applicant]
IL 288770B1 · 2023 [cited by applicant]
JP H0337030A · 1991 [cited by applicant]
JP H06218279A · 1994 [cited by applicant]
JP H1043128A · 1998 [cited by applicant]
JP 2002110397A · 2002 [cited by applicant]
JP 2003207601A · 2003 [cited by applicant]
JP 2003210556A · 2003 [cited by applicant]
JP 2006021027A · 2006 [cited by applicant]
JP 2006087514A · 2006 [cited by applicant]
JP 2006095173A · 2006 [cited by applicant]
JP 2009512467A · 2009 [cited by applicant]
JP 2018531767A · 2018 [cited by applicant]
JP 6678744B2 · 2020 [cited by applicant]
JP 2020114396A · 2020 [cited by applicant]
JP 6973818B2 · 2021 [cited by applicant]
JP 2022009584A · 2022 [cited by applicant]
JP 7084079B2 · 2022 [cited by applicant]
JP 2022105703A · 2022 [cited by applicant]
KR 20180054669A · 2018 [cited by applicant]
WO WO9504609 · 1995 [cited by applicant]
WO WO2006129472A1 · 2006 [cited by applicant]
WO WO2007032172A1 · 2007 [cited by applicant]
WO WO2009020105A1 · 2009 [cited by applicant]
WO WO2017042806A1 · 2017 [cited by examiner]
WO WO2017153898A1 · 2017 [cited by applicant]
WO WO2018167792A1 · 2018 [cited by applicant]
WO WO2022224040A2 · 2022 [cited by examiner]
International Preliminary Report on Patentability in International Application No. PCT/IL2018/050304, report completed May 8, 2019 (15 pages). [cited by applicant]
International Search Report and Written Opinion of the International Searching Authority in International Application No. PCT/IB2022/000240, mailed by the Israel Patent Office on Jan. 16, 2023 (19 pages). [cited by applicant]
International Search Report and Written Opinion of the International Searching Authority in International Application No. PCT/IL2016/050990, mailed by the Israel Patent Office on Jan. 3, 2017 (7 pages). [cited by applicant]
International Search Report and Written Opinion of the International Searching Authority in International Application No. PCT/IL2018/050304, mailed by the Israel Patent Office on Jul. 19, 2018 (12 pages). [cited by applicant]
Search Report from the Israel Patent Office (ILPO) for Application No. 288770, dated Apr. 4, 2022 (2 pages). [cited by applicant]